BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1988 related articles for article (PubMed ID: 22817889)

  • 1. A landscape of driver mutations in melanoma.
    Hodis E; Watson IR; Kryukov GV; Arold ST; Imielinski M; Theurillat JP; Nickerson E; Auclair D; Li L; Place C; Dicara D; Ramos AH; Lawrence MS; Cibulskis K; Sivachenko A; Voet D; Saksena G; Stransky N; Onofrio RC; Winckler W; Ardlie K; Wagle N; Wargo J; Chong K; Morton DL; Stemke-Hale K; Chen G; Noble M; Meyerson M; Ladbury JE; Davies MA; Gershenwald JE; Wagner SN; Hoon DS; Schadendorf D; Lander ES; Gabriel SB; Getz G; Garraway LA; Chin L
    Cell; 2012 Jul; 150(2):251-63. PubMed ID: 22817889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
    Krauthammer M; Kong Y; Ha BH; Evans P; Bacchiocchi A; McCusker JP; Cheng E; Davis MJ; Goh G; Choi M; Ariyan S; Narayan D; Dutton-Regester K; Capatana A; Holman EC; Bosenberg M; Sznol M; Kluger HM; Brash DE; Stern DF; Materin MA; Lo RS; Mane S; Ma S; Kidd KK; Hayward NK; Lifton RP; Schlessinger J; Boggon TJ; Halaban R
    Nat Genet; 2012 Sep; 44(9):1006-14. PubMed ID: 22842228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ppp6c haploinsufficiency accelerates UV-induced BRAF(V600E)-initiated melanomagenesis.
    Kanazawa K; Kishimoto K; Nomura M; Kurosawa K; Kato H; Inoue Y; Miura K; Fukui K; Yamashita Y; Sato I; Tsuji H; Watanabe T; Tanaka T; Yasuda J; Tanuma N; Shima H
    Cancer Sci; 2021 Jun; 112(6):2233-2244. PubMed ID: 33743547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of driver mutations in FFPE samples from patients with verified malignant melanoma.
    Malicherova B; Burjanivova T; Minarikova E; Kasubova I; Pecova T; Bobrovska M; Homola I; Lasabova Z; Plank L
    Neoplasma; 2019 Jan; 66(1):33-38. PubMed ID: 30509087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status of naevus-associated melanomas.
    Shitara D; Tell-Martí G; Badenas C; Enokihara MM; Alós L; Larque AB; Michalany N; Puig-Butille JA; Carrera C; Malvehy J; Puig S; Bagatin E
    Br J Dermatol; 2015 Sep; 173(3):671-80. PubMed ID: 25857817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
    Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA
    Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic driver mutations in melanoma.
    Reddy BY; Miller DM; Tsao H
    Cancer; 2017 Jun; 123(S11):2104-2117. PubMed ID: 28543693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
    Yin C; Zhu B; Zhang T; Liu T; Chen S; Liu Y; Li X; Miao X; Li S; Mi X; Zhang J; Li L; Wei G; Xu ZX; Gao X; Huang C; Wei Z; Goding CR; Wang P; Deng X; Cui R
    Cell; 2019 Feb; 176(5):1113-1127.e16. PubMed ID: 30712867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVB mutagenesis differs in
    Bowman RL; Hennessey RC; Weiss TJ; Tallman DA; Crawford ER; Murphy BM; Webb A; Zhang S; La Perle KM; Burd CJ; Levine RL; Shain AH; Burd CE
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34210801
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
    Mar VJ; Wong SQ; Logan A; Nguyen T; Cebon J; Kelly JW; Wolfe R; Dobrovic A; McLean C; McArthur GA
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1117-25. PubMed ID: 25043693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ Spectrum of oncogene mutations is different in melanoma subtypes].
    Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV
    Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing.
    Selvam K; Sivapragasam S; Poon GMK; Wyrick JJ
    Nat Commun; 2023 May; 14(1):2702. PubMed ID: 37169747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome landscapes of major melanoma subtypes.
    Hayward NK; Wilmott JS; Waddell N; Johansson PA; Field MA; Nones K; Patch AM; Kakavand H; Alexandrov LB; Burke H; Jakrot V; Kazakoff S; Holmes O; Leonard C; Sabarinathan R; Mularoni L; Wood S; Xu Q; Waddell N; Tembe V; Pupo GM; De Paoli-Iseppi R; Vilain RE; Shang P; Lau LMS; Dagg RA; Schramm SJ; Pritchard A; Dutton-Regester K; Newell F; Fitzgerald A; Shang CA; Grimmond SM; Pickett HA; Yang JY; Stretch JR; Behren A; Kefford RF; Hersey P; Long GV; Cebon J; Shackleton M; Spillane AJ; Saw RPM; López-Bigas N; Pearson JV; Thompson JF; Scolyer RA; Mann GJ
    Nature; 2017 May; 545(7653):175-180. PubMed ID: 28467829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
    Thomas NE; Edmiston SN; Alexander A; Millikan RC; Groben PA; Hao H; Tolbert D; Berwick M; Busam K; Begg CB; Mattingly D; Ollila DW; Tse CK; Hummer A; Lee-Taylor J; Conway K
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):991-7. PubMed ID: 17507627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Driver mutations in melanoma: lessons learned from bench-to-bedside studies.
    Mehnert JM; Kluger HM
    Curr Oncol Rep; 2012 Oct; 14(5):449-57. PubMed ID: 22723080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal architectures and driver mutations in metastatic melanomas.
    Ding L; Kim M; Kanchi KL; Dees ND; Lu C; Griffith M; Fenstermacher D; Sung H; Miller CA; Goetz B; Wendl MC; Griffith O; Cornelius LA; Linette GP; McMichael JF; Sondak VK; Fields RC; Ley TJ; Mulé JJ; Wilson RK; Weber JS
    PLoS One; 2014; 9(11):e111153. PubMed ID: 25393105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational Status of NRAS and BRAF Genes and Protein Expression Analysis in a Series of Primary Oral Mucosal Melanoma.
    Hsieh R; Nico MM; Camillo CM; Oliveira KK; Sangueza M; Lourenço SV
    Am J Dermatopathol; 2017 Feb; 39(2):104-110. PubMed ID: 28134726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.